WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2023)
Top pharmaceutical stocks in 2023 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Performance Score
Market Cap
Revenue
EBITDA
Earnings
EPS
Revenue Growth Y/Y
Revenue Growth 5Y
Earnings Growth Y/Y
Earnings Growth 5Y
Earnings Date
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.65B$410.60M$261.44M$175.07M$1.13-0.76%6.60%-65.34%N/A2023-05-03
AMPH
AMPHASTAR PHARMACEUTICALS INC
$1.80B$498.99M$144.03M$91.39M$1.8813.98%15.75%44.62%88.02%2023-05-08
ASRT
ASSERTIO HOLDINGS INC
$325.69M$156.23M$72.52M$109.63M$2.3340.73%-16.32%N/AN/A2023-05-08
VTRS
VIATRIS INC
$11.17B$16.26B$6.43B$2.08B$1.71-9.08%6.43%N/A5.64%2023-05-08
PRPH
PROPHASE LABS INC
$130.06M$145.98M$43.95M$31.50M$2.05273.85%86.42%N/A-2.61%2023-03-28
OGI
ORGANIGRAM HOLDINGS INC
$198.67M$118.47M$13.19M-$5.71M-$0.0269.36%N/AN/AN/A2023-04-10
ACRX
ACELRX PHARMACEUTICALS INC
$5.21M$1.52M$50.48M$47.14M$6.26-57.20%-35.56%N/AN/A2023-03-30
ORGO
ORGANOGENESIS HOLDINGS INC
$247.92M$450.89M$40.32M$15.53M$0.12-3.52%17.83%-83.56%N/A2023-05-08
PAHC
PHIBRO ANIMAL HEALTH CORP
$594.59M$972.05M$103.51M$36.24M$0.9010.54%4.39%-31.30%-10.30%2023-05-02
EGRX
EAGLE PHARMACEUTICALS INC
$347.78M$316.61M$78.75M$35.64M$2.7684.56%5.99%N/A-4.31%2023-05-08
SNDL
SNDL INC
$371.83M$360.96M-$147.31M-$193.39M-$0.82906.69%N/AN/AN/A2023-04-25
ZTS
ZOETIS INC
$76.08B$8.08B$3.35B$2.11B$4.513.91%8.77%5.13%20.71%2023-05-03
CRON
CRONOS GROUP INC
$738.32M$91.90M-$143.97M-$168.73M-$0.4523.47%96.38%N/AN/A2023-05-08
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
$915.25M$569.41M$92.60M$64.98M$1.730.32%-5.31%810.53%-26.62%2023-05-24
RDY
DR REDDYS LABORATORIES LTD
$9.12B$2.73B$575.00M$300.61M$1.818.85%5.35%31.71%10.90%2023-05-12
GHSI
GUARDION HEALTH SCIENCES INC
$6.37M$10.95M-$19.26M-$20.54M-$36.50127.87%117.03%N/AN/A2023-03-30
ZOM
ZOMEDICA CORP
$205.79M$18.93M-$19.80M-$17.86M-$0.02358.02%N/AN/AN/A2023-05-08
SLDB
SOLID BIOSCIENCES INC
$72.03M$8.09M-$83.57M-$85.98M-$10.10-40.57%N/AN/AN/A2023-04-25
INCR
INTERCURE LTD
$94.78M$104.25M$18.42M$9.54M$0.2495.18%N/AN/AN/A2023-05-15
TLRY
TILRAY BRANDS INC
$1.61B$602.54M-$427.50M-$577.90M-$1.052.25%69.45%N/AN/A2023-04-04
SBFM
SUNSHINE BIOPHARMA INC
$17.62M$490.88k-$2.51M-$2.57M-$5.07186.53%N/AN/AN/A
CLVR
CLEVER LEAVES HOLDINGS INC
$16.91M$17.38M-$55.14M-$61.35M-$2.0219.64%N/AN/AN/A2023-03-30
TAK
TAKEDA PHARMACEUTICAL CO LTD
$54.51B$52.85B$12.41B$4.19B$1.3571.42%N/A8.53%N/A2023-05-11
EVOK
EVOKE PHARMA INC
$7.72M$2.51M-$7.69M-$8.22M-$2.6255.04%N/AN/AN/A2023-05-08
BFRI
BIOFRONTERA INC
$16.55M$28.67M$759.00k-$640.00k-$0.0318.98%N/AN/AN/A2023-05-12
SXTC
CHINA SXT PHARMACEUTICALS INC
$1.02M$339.22k-$3.47M-$4.14M-$2.10N/AN/AN/AN/A
RMTI
ROCKWELL MEDICAL INC
$16.29M$68.83M-$20.56M-$25.26M-$2.7911.44%4.27%N/AN/A2023-03-30
HROW
HARROW HEALTH INC
$552.01M$88.60M-$3.10M-$14.09M-$0.5122.24%27.04%N/AN/A2023-05-03
ZYNE
ZYNERBA PHARMACEUTICALS INC
$20.24M$0.00-$35.61M-$35.83M-$0.87N/AN/AN/AN/A2023-05-15
CALT
CALLIDITAS THERAPEUTICS AB
$673.81M$32.37M-$59.30M-$57.37M-$2.1871,386.25%N/AN/AN/A2023-05-16
DRRX
DURECT CORP
$107.73M$19.28M-$32.82M-$35.33M-$1.5537.96%-17.07%N/AN/A2023-05-02
OPTN
OPTINOSE INC
$205.73M$76.28M-$57.46M-$74.83M-$0.872.18%N/AN/AN/A2023-05-10
SISI
SHINECO INC
$12.85M$1.90M-$13.84M-$15.13M-$1.27-26.57%-45.06%N/AN/A
ANIP
ANI PHARMACEUTICALS INC
$658.33M$316.39M$25.04M-$49.52M-$3.0546.38%12.34%N/AN/A2023-05-08
PLXP
PLX PHARMA INC
$4.43M$4.54M-$27.51M-$27.58M-$0.84-31.32%59.64%N/AN/A2023-05-11
CGC
CANOPY GROWTH CORP
$940.30M$331.55M-$2.29B-$2.36B-$5.80-26.03%42.47%N/AN/A2023-05-25
ACB
AURORA CANNABIS INC
$240.40M$159.09M-$1.23B-$1.32B-$5.77-14.30%N/AN/AN/A2023-05-10
SCYX
SCYNEXIS INC
$61.07M$4.16M-$76.98M-$77.62M-$2.21-66.86%74.68%N/AN/A2023-03-27
RLMD
RELMADA THERAPEUTICS INC
$68.33M$0.00-$157.04M-$157.04M-$5.30N/AN/AN/AN/A2023-05-03
NLTX
NEOLEUKIN THERAPEUTICS INC
$27.15M$0.00-$54.95M-$57.56M-$1.04N/AN/AN/AN/A2023-05-08
JUPW
JUPITER WELLNESS INC
$8.76M$6.84M-$22.25M-$23.64M-$1.20315.90%N/AN/AN/A
PRFX
PAINREFORM LTD
$7.12M$0.00-$8.77M-$8.79M-$0.82N/AN/AN/AN/A
DERM
JOURNEY MEDICAL CORP
$23.55M$75.22M-$23.71M-$40.74M-$2.9726.76%N/AN/AN/A2023-03-29
TXMD
THERAPEUTICSMD INC
$36.54M$87.49M$34.33M-$8.67M-$0.99-3.70%38.54%N/AN/A2023-05-15
MDVL
MEDAVAIL HOLDINGS INC
$22.57M$39.04M-$44.24M-$49.17M-$1.10117.50%150.47%N/AN/A2023-03-30
SCTL
SOCIETAL CDMO INC
$99.32M$90.21M$3.60M-$19.88M-$0.3419.71%4.66%N/AN/A2023-05-09
KMDA
KAMADA LTD
$195.92M$129.34M$10.81M-$2.32M-$0.0524.79%4.70%N/AN/A2023-05-15
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$51.84M$59.25M$2.13M$890.15k$0.0213.47%N/A-81.82%N/A
CPIX
CUMBERLAND PHARMACEUTICALS INC
$28.36M$42.01M$412.72k-$5.57M-$0.3816.75%0.41%N/AN/A2023-05-08
PROC
PROCAPS GROUP SA
$539.30M$434.99M-$726.00k-$14.19MN/A8.38%N/AN/AN/A2023-05-01
CTLT
CATALENT INC
$11.57B$4.76B$1.05B$409.00M$2.276.11%15.65%-31.00%31.38%2023-05-01
YCBD
CBDMD INC
$13.02M$32.17M-$51.96M-$58.88M-$0.98-22.44%45.32%N/AN/A2023-05-11
ATNX
ATHENEX INC
$12.04M$102.82M-$74.92M-$103.43M-$15.817.81%22.00%N/AN/A2023-05-08
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.95B$667.24M$153.36M$60.71M$1.1315.09%17.16%11.88%0.00%2023-05-08
EOLS
EVOLUS INC
$476.11M$148.62M-$60.72M-$74.41M-$1.3349.10%N/AN/AN/A2023-05-08
NEPT
NEPTUNE WELLNESS SOLUTIONS INC
$5.75M$55.97M-$83.30M-$91.09M-$14.6983.78%N/AN/AN/A
XXII
22ND CENTURY GROUP INC
$161.56M$62.11M-$56.29M-$59.80M-$0.31100.69%30.20%N/AN/A2023-05-03
CRDL
CARDIOL THERAPEUTICS INC
$31.84M$0.00-$21.50M-$21.66M-$0.33-100.00%N/AN/AN/A2023-03-27
IXHL
INCANNEX HEALTHCARE LTD
$62.21M$788.65k-$18.19M-$18.19M-$0.70-0.95%N/AN/AN/A
PRGO
PERRIGO CO PLC
$4.56B$4.45B$345.80M-$140.60M-$1.047.56%-2.09%N/AN/A2023-05-09
SNOA
SONOMA PHARMACEUTICALS INC
$4.70M$12.56M-$6.88M-$6.79M-$2.310.55%-5.92%N/AN/A
HEXO
HEXO CORP
$55.81M$107.31M-$240.76M-$226.02M-$4.15-15.96%N/AN/AN/A
PETQ
PETIQ INC
$348.14M$921.51M$15.85M-$48.21M-$1.65-1.18%28.14%N/AN/A2023-05-02
AMYT
AMRYT PHARMA PLC
$933.35M$243.62M$92.80M-$790.00k$0.3515.88%N/AN/AN/A2023-05-03
THTX
THERATECHNOLOGIES INC
$79.38M$59.30M-$28.46M-$34.99M-$0.3710.35%15.68%N/AN/A2023-04-11
HUGE
FSD PHARMA INC
$56.03M$0.00-$14.04M-$17.38M-$0.43N/AN/AN/AN/A2023-03-29
PCRX
PACIRA BIOSCIENCES INC
$1.80B$666.82M$144.78M$15.91M$0.3523.14%18.40%-63.16%N/A2023-05-02
PTPI
PETROS PHARMACEUTICALS INC
$2.90M$4.33M-$17.05M-$24.00M-$15.20-62.72%N/AN/AN/A
AGRX
AGILE THERAPEUTICS INC
$10.70M$10.88M-$25.42M-$25.41M-$1.18165.40%N/AN/AN/A2023-05-10
RDHL
REDHILL BIOPHARMA LTD
$8.30M$76.21M-$32.87M-$88.92M-$64.00-10.50%104.98%N/AN/A
TKNO
ALPHA TEKNOVA INC
$82.70M$43.64M-$36.88M-$37.82M-$1.3218.13%N/AN/AN/A2023-05-10
EVO
EVOTEC SE
$3.37B$704.88M-$82.82M-$181.75M-$8.533.79%69.99%N/AN/A2023-03-28
ALVO
ALVOTECH
$3.35B$83.03M-$342.82M-$513.58M-$2.60125.79%N/AN/AN/A2023-05-17
PAVS
PARANOVUS ENTERTAINMENT TECHNOLOGY LTD
$20.17M$95.59M-$56.22M-$58.51M-$26.60-0.93%N/AN/AN/A
AKAN
AKANDA CORP
$3.27MN/AN/AN/AN/AN/AN/AN/AN/A
FLGC
FLORA GROWTH CORP
$17.80MN/AN/AN/AN/AN/AN/AN/AN/A2023-05-09
EBS
EMERGENT BIOSOLUTIONS INC
$406.14M$1.12B-$41.10M-$223.80M-$4.47-37.47%14.85%N/AN/A2023-04-26
CYTH
CYCLO THERAPEUTICS INC
$9.60M$1.38M-$15.43M-$15.45M-$1.83-13.24%2.14%N/AN/A2023-05-16
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$335.60M$0.00-$7.14M-$7.74M-$0.58N/AN/AN/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$1.85M$8.07M-$245.67k-$3.69M-$0.80-16.64%-11.21%N/AN/A2023-03-31
EMBC
EMBECTA CORP
$1.74B$1.12B$298.40M$160.00M$2.83-4.57%N/A-60.64%N/A2023-05-11
AMRX
AMNEAL PHARMACEUTICALS INC
$403.81M$2.21B$275.23M-$129.99M-$0.865.67%16.44%N/AN/A2023-05-02
BHC
BAUSCH HEALTH COMPANIES INC
$2.62B$8.12B$2.72B-$225.00M-$0.62-3.68%-1.41%N/AN/A2023-05-08
COSM
COSMOS HEALTH INC
$12.00M$54.47M-$219.61k-$34.95M-$46.75-3.35%18.80%N/AN/A
VERU
VERU INC
$111.31M$27.73M-$109.87M-$114.24M-$1.44-54.38%16.36%N/AN/A2023-05-10
ADMP
ADAMIS PHARMACEUTICALS CORP
$17.85M$4.76M-$25.04M-$26.48M-$0.18115.34%-18.31%N/AN/A2023-05-15
BGXX
BRIGHT GREEN CORP
$164.26MN/AN/AN/AN/AN/AN/AN/AN/A
LCI
LANNETT CO INC
$17.12M$308.52M-$105.90M-$192.52M-$18.88-24.09%-13.58%N/AN/A2023-05-02
ELAN
ELANCO ANIMAL HEALTH INC
$4.34B$4.41B$851.00M-$78.00M-$0.16-7.41%8.83%N/AN/A2023-05-08
UPXI
UPEXI INC
$74.00M$64.11M$3.19M-$2.61M-$0.16148.05%N/AN/AN/A2023-05-15
COLL
COLLEGIUM PHARMACEUTICAL INC
$809.76M$463.93M$173.54M-$25.00M-$0.7467.56%74.74%N/AN/A2023-05-08
ALIM
ALIMERA SCIENCES INC
$9.47M$54.06M-$10.15M-$18.43M-$2.67-8.13%7.62%N/AN/A2023-05-08
AVDL
AVADEL PHARMACEUTICALS PLC
$583.19M$0.00-$96.37M-$132.32M-$2.23N/A-100.00%N/AN/A2023-05-08
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$9.38B$14.93B-$717.00M-$2.35B-$2.12-6.00%-7.34%N/AN/A2023-05-04
MNK
MALLINCKRODT PLC
$106.03MN/AN/AN/AN/AN/AN/AN/AN/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Mar 2023?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the top pharmaceutical stock with a Zen Score of 52, which is 27 points higher than the pharmaceutical industry average of 25. It passed 16 out of 33 due diligence checks and has strong fundamentals. Ironwood Pharmaceuticals has seen its stock lose -16.22% over the past year, overperforming other pharmaceutical stocks by 29 percentage points.

2. Amphastar Pharmaceuticals (NASDAQ:AMPH)


Amphastar Pharmaceuticals (NASDAQ:AMPH) is the second best pharmaceutical stock with a Zen Score of 47, which is 22 points higher than the pharmaceutical industry average of 25. It passed 15 out of 33 due diligence checks and has strong fundamentals. Amphastar Pharmaceuticals has seen its stock return 5.03% over the past year, overperforming other pharmaceutical stocks by 50 percentage points.

Amphastar Pharmaceuticals has an average 1 year price target of $38.00, an upside of 1.14% from Amphastar Pharmaceuticals's current stock price of $37.57.

Amphastar Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Amphastar Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Assertio Holdings (NASDAQ:ASRT)


Assertio Holdings (NASDAQ:ASRT) is the third best pharmaceutical stock with a Zen Score of 46, which is 21 points higher than the pharmaceutical industry average of 25. It passed 14 out of 33 due diligence checks and has strong fundamentals. Assertio Holdings has seen its stock return 97.97% over the past year, overperforming other pharmaceutical stocks by 143 percentage points.

Assertio Holdings has an average 1 year price target of $7.50, an upside of 27.99% from Assertio Holdings's current stock price of $5.86.

Assertio Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Assertio Holdings, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) has an annual dividend yield of 3.86%, which is 1 percentage points higher than the pharmaceutical industry average of 2.39%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of 21.1% indicates that its dividend yield is sustainable for the long-term.

2. Prophase Labs (NASDAQ:PRPH)


Prophase Labs (NASDAQ:PRPH) has an annual dividend yield of 3.75%, which is 1 percentage points higher than the pharmaceutical industry average of 2.39%.

Prophase Labs's dividend payout ratio of 29.3% indicates that its dividend yield is sustainable for the long-term.

3. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.27%, which is 1 percentage points higher than the pharmaceutical industry average of 2.39%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 53.3% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 1.45% in the last day, and down -0.8% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are up.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)


Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Ironwood Pharmaceuticals has a valuation score of 86, which is 58 points higher than the pharmaceutical industry average of 28. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has dropped -16.22% in the past year. It has overperformed other stocks in the pharmaceutical industry by 29 percentage points.

2. Acelrx Pharmaceuticals (NASDAQ:ACRX)


Acelrx Pharmaceuticals (NASDAQ:ACRX) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Acelrx Pharmaceuticals has a valuation score of 71, which is 43 points higher than the pharmaceutical industry average of 28. It passed 5 out of 7 valuation due diligence checks.

Acelrx Pharmaceuticals's stock has dropped -89.2% in the past year. It has underperformed other stocks in the pharmaceutical industry by -44 percentage points.

3. Organogenesis Holdings (NASDAQ:ORGO)


Organogenesis Holdings (NASDAQ:ORGO) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Organogenesis Holdings has a valuation score of 71, which is 43 points higher than the pharmaceutical industry average of 28. It passed 5 out of 7 valuation due diligence checks.

Organogenesis Holdings's stock has dropped -74.25% in the past year. It has underperformed other stocks in the pharmaceutical industry by -29 percentage points.

Are pharmaceutical stocks a good buy now?

43.14% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 53.61% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 18.14x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.